Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of MBD1 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | ELISA,ChIP |
More info about MBD1 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB14126 |
| Product name: | MBD1 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of MBD1. |
| Gene id: | 4152 |
| Gene name: | MBD1 |
| Gene alias: | CXXC3|PCM1|RFT |
| Gene description: | methyl-CpG binding domain protein 1 |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human MBD1. |
| Protein accession: | Q9UIS9 |
| Form: | Liquid |
| Recommend dilutions: | ELISA (1:300-1:1000) ChIP (1.7 ug/ChIP) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.05% sodium azide, 0.05% proclin 300) |
| Storage instruction: | Store at -20°C. For long term storage store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | ELISA was performed using a serial dilution of MBD1 polyclonal antibody (Cat # PAB14126), crude serum and Flow Through in antigen coated wells. By plotting the absorbance against the antibody dilution, the titer of the purified antibody was estimated to be 1 : 16,500. |
| Applications: | ELISA,ChIP |
| Shipping condition: | Dry Ice |
| Publications: | hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.Xiong Y, Dowdy SC, Eberhardt NL, Podratz KC, Jiang SW. Gynecol Oncol. 2006 Oct;103(1):321-8. Epub 2006 May 15. |